Nothing Special   »   [go: up one dir, main page]

Cighetti et al., 2014 - Google Patents

Modulation of CD14 and TLR4⋅ MD‐2 activities by a synthetic lipid A mimetic

Cighetti et al., 2014

View HTML
Document ID
15737698003069992638
Author
Cighetti R
Ciaramelli C
Sestito S
Zanoni I
Kubik
Ardá‐Freire A
Calabrese V
Granucci F
Jerala R
Martín‐Santamaría S
Jiménez‐Barbero J
Peri F
Publication year
Publication venue
ChemBioChem

External Links

Snippet

Monosaccharide lipid A mimetics based on a glucosamine core linked to two fatty acid chains and bearing one or two phosphate groups have been synthesized. Compounds 1 and 2, each with one phosphate group, were practically inactive in inhibiting LPS‐induced …
Continue reading at www.ncbi.nlm.nih.gov (HTML) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7088—Compounds having three or more nucleosides or nucleotides
    • A61K31/711—Natural deoxyribonucleic acids, i.e. containing only 2'-deoxyriboses attached to adenine, guanine, cytosine or thymine and having 3'-5' phosphodiester links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48007—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the pharmacologically- or therapeutically-active agent being covalently bound or complexed to a modifying agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Similar Documents

Publication Publication Date Title
Cighetti et al. Modulation of CD14 and TLR4⋅ MD‐2 activities by a synthetic lipid A mimetic
Nagata et al. Intracellular metabolite β-glucosylceramide is an endogenous Mincle ligand possessing immunostimulatory activity
Di Lorenzo et al. Pairing Bacteroides vulgatus LPS structure with its immunomodulatory effects on human cellular models
Nycholat et al. A sulfonamide sialoside analogue for targeting Siglec-8 and-F on immune cells
Komarova et al. Synthesis of a pentasaccharide and neoglycoconjugates related to fungal α‐(1→ 3)‐glucan and their use in the generation of antibodies to trace Aspergillus fumigatus cell wall
Facchini et al. Structure–activity relationship in monosaccharide-based toll-like receptor 4 (TLR4) antagonists
Rademacher et al. Ligand specificity of CS-35, a monoclonal antibody that recognizes mycobacterial lipoarabinomannan: a model system for oligofuranoside− protein recognition
Murphy et al. Reversing hypoxia with PLGA-encapsulated manganese dioxide nanoparticles improves natural killer cell response to tumor spheroids
Mesch et al. From a library of MAG antagonists to nanomolar CD22 ligands
NZ740338A (en) Compositions and methods for modulating apolipoprotein (a) expression
Movsisyan et al. Structural advances of Siglecs: insight into synthetic glycan ligands for immunomodulation
MacDougall et al. Design, chemical synthesis, and biological evaluation of thiosaccharide analogues of morphine-and codeine-6-glucuronide
van der Kaaden et al. Synthesis and antifungal properties of papulacandin derivatives
Podvalnyy et al. Rapid synthesis of linear homologous oligoarabinofuranosides related to mycobacterial lipoarabinomannan and a neoglycoconjugate thereof
Borio et al. Disaccharide‐based anionic amphiphiles as potent inhibitors of lipopolysaccharide‐induced inflammation
Valverde et al. Molecular insights into DC-SIGN binding to self-antigens: The interaction with the blood group A/B antigens
Hollaus et al. Chemical synthesis of Burkholderia lipid A modified with glycosyl phosphodiester‐linked 4‐amino‐4‐deoxy‐β‐l‐arabinose and its immunomodulatory potential
Xue et al. Convergent synthesis of a GPI containing an acylated inositol
Ciaramelli et al. Glycolipid‐based TLR 4 Modulators and Fluorescent Probes: Rational Design, Synthesis, and Biological Properties
Komazin et al. Substrate structure-activity relationship reveals a limited lipopolysaccharide chemotype range for intestinal alkaline phosphatase
Cao et al. Therapeutic interventions targeting innate immune receptors: a balancing act
Ziaco et al. Development of clickable monophosphoryl lipid A derivatives toward semisynthetic conjugates with tumor-associated carbohydrate antigens
Nielsen et al. Synthetic agonists of NOD-like, RIG-I-like, and C-type lectin receptors for probing the inflammatory immune response
Twibanire et al. Facile synthesis of a library of lyme disease glycolipid antigens
Zhang et al. Introduction of aromatic group on 4′-OH of α-GalCer manipulated NKT cell cytokine production